Flow cytometry and its use in the diagnosis and management of mature lymphoid malignancies

Histopathology

Volumn 58, Issue 1, 2011, Pages 90-105

  De Tute, Ruth M ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Diagnosis; Flow cytometry; Lymphoid neoplasm; Lymphoma

Indexed keywords

ALEMTUZUMAB; ALPHA4 INTEGRIN; CD103 ANTIGEN; CD16 ANTIGEN; CD19 ANTIGEN; CD2 ANTIGEN; CD20 ANTIGEN; CD200 ANTIGEN; CD23 ANTIGEN; CD3 ANTIGEN; CD38 ANTIGEN; CD5 ANTIGEN; CD52 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; CD79B ANTIGEN; CD81 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; INTERLEUKIN 2 RECEPTOR ALPHA; LEUKOSIALIN; PROTEIN BCL 2; PROTEIN KINASE ZAP 70; RITUXIMAB; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T6 ANTIGEN; UNINDEXED DRUG;

ASPIRATION BIOPSY; B LYMPHOCYTE; BONE MARROW; CANCER CELL; CELL LINEAGE; CELL POPULATION; CHRONIC LYMPHATIC LEUKEMIA; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; HAIRY CELL LEUKEMIA; HODGKIN DISEASE; HUMAN; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; LYMPHOMA; LYMPHOMA CELL; LYMPHOPROLIFERATIVE DISEASE; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; NEEDLE BIOPSY; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; PROTEIN EXPRESSION; REVIEW; SENSITIVITY AND SPECIFICITY; SEZARY SYNDROME; T LYMPHOCYTE; WORLD HEALTH ORGANIZATION;

ANIMALS; FLOW CYTOMETRY; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA; LYMPHOMA; LYMPHOMA, B-CELL;

EID: 78851469166     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03703.x     Document Type: Review

References (54)

1. Jaffe ES, Harris NL, Stein H, Isaacson PG. Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood 2008; 11; 4384-4399.
2. Jaffe E, Harris N, Stein H. Tumours of the haematopoietic and lymphoid tissues. World Health Organisation classification of tumours. Lyon, France: International Agency for Research on Cancer, 2001.
3. Swerdlow S, Campo E, Harris N et al. WHO Classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: International Agency for Research on Cancer, 2008.
4. Wood BL, Arroz M, Barnett D et al. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Cytometry. B Clin. Cytom. 2007; 72(Suppl. 1); S14-S22.
5. McMichael AJ, Pilch JR, Galfré G et al. A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody. Eur. J. Immunol. 1979; 9; 205-210.
6. Wood B. 9-color and 10-color flow cytometry in the clinical laboratory. Arch. Pathol. Lab. Med. 2006; 130; 680-690.
7. Nadler LM, Ritz J, Hardy R et al. A unique cell surface antigen identifying lymphoid malignancies of B cell origin. J. Clin. Invest. 1981; 67; 134-140.
8. Yang W, Agrawal N, Patel J et al. Diminished expression of CD19 in B cell lymphomas. Cytometry. B Clin. Cytom. 2005; 63B; 28-35.
9. Kroft SH. Monoclones, monotypes, and neoplasia pitfalls in lymphoma diagnosis. Am. J. Clin. Pathol. 2004; 121; 457-459.
10. Morice WG, Kurtin PJ, Hodnefield JM et al. Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients. Mayo Clin. Proc. 2008; 83; 776-785.
11. Matutes E. New additions to antibody panels in the characterisation of chronic lymphoproliferative disorders. J. Clin. Pathol. 2002; 55; 180-183.
12. Hiraga J, Tomita A, Sugimoto T et al. Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance. Blood 2009; 113; 4885-4893.
13. Trojani A, Montillo M, Tedeschi A et al. ZAP-70, IgVh, and cytogenetics for assessing prognosis in chronic lymphocytic leukemia. Cancer Biomark. 2010; 6; 1-9.
14. Gattei V, Bulian P, Del Principe MI et al. Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia. Blood 2008; 111; 865-873.
15. Moreton P, Kennedy B, Lucas G et al. Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival. J. Clin. Oncol. 2005; 23; 2971-2979.
16. Talaulikar D, Shadbolt B, Bell J et al. Clinical role of flow cytometry in redefining bone marrow involvement in diffuse large B-cell lymphoma (DLBCL) - a new perspective. Histopathology 2008; 52; 340-347.
17. Rawstron AC, Villamor N, Ritgen M et al. International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia. Leukemia 2007; 21; 956-964.
18. Dong HY, Weisberger J, Liu Z, Tugulea S. Immunophenotypic analysis of CD103+ B-lymphoproliferative disorders: hairy cell leukemia and its mimics. Am. J. Clin. Pathol. 2009; 131; 586-595.
19. Sausville JE, Salloum RG, Sorbara L et al. Minimal residual disease detection in hairy cell leukemia. Comparison of flow cytometric immunophenotyping with clonal analysis using consensus primer polymerase chain reaction for the heavy chain gene. Am. J. Clin. Pathol. 2003; 119; 213-217.
20. Swerdlow SH, Williams ME. From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades. Hum. Pathol. 2002; 33; 7-20.
21. Palumbo GA, Parrinello N, Fargione G et al. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia. Leuk. Res. 2009; 33; 1212-1216.
22. Cook JR, Craig FE, Swerdlow SH. bcl-2 Expression by multicolor flow cytometric analysis assists in the diagnosis of follicular lymphoma in lymph node and bone marrow. Am. J. Clin. Pathol. 2003; 119; 145-151.
23. Laane E, Tani E, Bjorklund E et al. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma. Cytometry. B Clin. Cytom. 2005; 64B; 34-42.
24. Dunphy CH. Gene expression profiling data in lymphoma and leukemia: review of the literature and extrapolation of pertinent clinical applications. Arch. Pathol. Lab. Med. 2006; 130; 483-520.
25. Rawstron AC, de Tute R, Jack AS, Hillmen P. Flow cytometric protein expression profiling as a systematic approach for developing disease-specific assays: identification of a chronic lymphocytic leukaemia-specific assay for use in rituximab-containing regimens. Leukemia 2006; 20; 2102-2110.
26. Bertram HC, Check IJ, Milano MA. Immunophenotyping large B-cell lymphomas. Am. J. Clin. Pathol. 2001; 116; 191-203.
27. Morice WG, Chen D, Kurtin PJ, Hanson CA, McPhail ED. Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenström's macroglobulinemia. Mod. Pathol. 2009; 22; 807-816.
28. Hudnall SD, Betancourt E, Barnhart E, Patel J. Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia. Cytometry. B Clin. Cytom. 2008; 74B; 1-8.
29. Fromm JR, Thomas A, Wood BL. Flow cytometry can diagnose classical Hodgkin lymphoma in lymph nodes with high sensitivity and specificity. Am. J. Clin. Pathol. 2009; 131; 322-332.
30. van den Beemd R, Boor PPC, van Lochem EG et al. Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry 2000; 40; 336-345.
31. Salameire D, Le Bris Y, Fabre B et al. Efficient characterization of the TCR repertoire in lymph nodes by flow cytometry. Cytometry A 2009; 75; 743-751.
32. Giachino C, Granziero L, Modena V et al. Clonal expansions of V delta 1+ and V delta 2+ cells increase with age and limit the repertoire of human gamma delta T cells. Eur. J. Immunol. 1994; 24; 1914-1918.
33. Kinney MC, Jones D. Cutaneous T-cell and NK-cell lymphomas: the WHO-EORTC classification and the increasing recognition of specialized tumor types. Am. J. Clin. Pathol. 2007; 127; 670-686.
34. Muzzafar T, Wei EX, Lin P, Medeiros LJ, Jorgensen JL. Flow cytometric immunophenotyping of anaplastic large cell lymphoma. Arch. Pathol. Lab. Med. 2009; 133; 49-56.
35. Dunphy CH. Contribution of flow cytometric immunophenotyping to the evaluation of tissues with suspected lymphoma? Cytometry 2000; 42; 296-306.
36. Sandhaus LM. Fine-needle aspiration cytology in the diagnosis of lymphoma. Am. J. Clin. Pathol. 2000; 113; 623-627.
37. Gong JZ, Williams DC, Liu K, Jones C. Fine-needle aspiration in non-Hodgkin lymphoma. Am. J. Clin. Pathol. 2002; 117; 880-888.
38. Meda BL, Buss BA, Woodruff RD et al. Diagnosis and subclassification of primary and recurrent lymphoma. Am. J. Clin. Pathol. 2000; 113; 688-699.
39. Maroto A, Martinez M, Martinez MA, de Agustin P, Rodriguez-Peralto JL. Comparative analysis of immunoglobulin polymerase chain reaction and flow cytometry in fine needle aspiration biopsy differential diagnosis of non-Hodgkin B-cell lymphoid malignancies. Diagn. Cytopathol. 2009; 37; 647-653.
40. Rawstron AC, Bennett FL, O'Connor SJM et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N. Engl. J. Med. 2008; 359; 575-583.
41. Nieto WG, Almeida J, Romero A et al. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach. Blood 2009; 114; 33-37.
42. Talaulikar D, Dahlstrom JE. Staging bone marrow in diffuse large B-cell lymphoma: the role of ancillary investigations. Pathology 2009; 41; 214-222.
43. Dagklis A, Fazi C, Scarfo L, Apollonio B, Ghia P. Monoclonal B lymphocytosis in the general population. Leuk. Lymphoma 2009; 50; 490-492.
44. Rawstron AC, Hillmen P. Clinical and diagnostic implications of monoclonal B-cell lymphocytosis. Best Pract. Res. Clin. Haematol. 2010; 23; 61-69.
45. Greig B, Oldaker T, Warzynski M, Wood B. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: recommendations for training and education to perform clinical flow cytometry. Cytometry. B Clin. Cytom. 2007; 72(Suppl. 1); S23-S33.
46. Euroflow. Flow cytometry for fast and sensitive diagnosis and follow-up of haematological malignancies. Available at: Last accessed 10 November 2010.
47. Pedreira CE, Costa ES, Barrena S et al. Generation of flow cytometry data files with a potentially infinite number of dimensions. Cytometry A 2008; 73; 834-846.
48. Pedreira CE, Costa ES, Almeida J et al. A probabilistic approach for the evaluation of minimal residual disease by multiparameter flow cytometry in leukemic B-cell chronic lymphoproliferative disorders. Cytometry A 2008; 73A; 1141-1150.
49. Zuba-Surma EK, Kucia M, Abdel-Latif A, Lillard JW, Ratajczak MZ. The ImageStream System: a key step to a new era in imaging. Folia Histochem. Cytobiol. 2007; 45; 279-290.
50. McGrath KE, Bushnell TP, Palis J. Multispectral imaging of hematopoietic cells: where flow meets morphology. J. Immunol. Methods 2008; 336; 91-97.
51. Jasionowski TM, Hartung L, Greenwood JH, Perkins SL, Bahler DW. Analysis of CD10+ hairy cell leukemia. Am. J. Clin. Pathol. 2003; 120; 228-235.
52. Robbins BA, Ellison DJ, Spinosa JC et al. Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. Blood 1993; 82; 1277-1287.
53. Xu Y, McKenna RM, Kroft SH. Assessment of CD10 in the diagnosis of small B-cell lymphomas. Am. J. Clin. Pathol. 2002; 117; 291-300.
54. Kelemen K, Guitart J, Kuzel TM, Goolsby CL, Peterson LC. The usefulness of CD26 in flow cytometric analysis of peripheral blood in Sézary syndrome. Am. J. Clin. Pathol. 2008; 129; 146-156.